With another piece of must-pass legislation set to move through Congress, there’s a push to attach provisions to keep afloat a number of health-related programs for which funding or specific federal direction has expired.
In Louisiana, the wining and dining of lawmakers by scores of pharma lobbyists proves a valuable lesson on how to win statehouse votes and influence profits, though their efforts fell short in California, which passed a drug transparency bill in 2017 despite massive opposition from drugmakers.
Based on research conducted at the University of Michigan’s medical center, a group of surgeons developed a strategy to help post-surgical patients from misusing or abusing their prescription painkillers.
The price for Pfizer’s Prevnar 13 has increased 5 to 6 percent each year since its 2010 approval by the Food and Drug Administration.
Feeling fidgety about U.S. PIRG’s latest report? KHN gets experts to weigh in with their thoughts about the findings and consumers’ risks.
The Vermont senator found a friendly audience when he took his “Medicare-for-all message” to Canada.
El senador por Vermont realizó un viaje para aprender más sobre un sistema de salud que es similar al que propone para los Estados Unidos.
Expertos dicen que farmacéuticas están apelando al miedo de los padres para promover dos vacunas contra le meningitis B entre estudiantes universitarios, luego de dos brotes en campus.
After weathering the catastrophe in New Orleans 12 years ago, Dr. Ruth Berggren moved to Texas, where she again finds herself in the center of a hurricane crisis. In a Q&A, she draws parallels between the harrowing events and pinpoints risks in Harvey’s aftermath.
This immunization may mark a shift among some vaccine makers to higher-priced, “niche” preventives that protect against very specific and sometimes rare illnesses.